aod9604 weight loss evidence clinical trials AOD-9604 vs MOTS-c vs Tesamorelin vs Semaglutide vs Tirzepatide aod9604 phase 2 trial results

Available from: Fadul A, Abdalla E, Mohamed A, Ali B, Elamin N, Alsayed AA, Al-Mashdali AF, Singh K, Mohamed SF

This active component has the same function as growth hormone naturally expressed in the human body

And for ongoing tips, lab best practices, and updates from our team, be sure to follow us on Facebook

Peptide Therapy Peptide Therapy Sources & References 8 Verified resources from our clinical research database

They arrive in a discreet package

United States (FDA and DSHEA) Not FDA-approved for weight loss or fat-burning claims AOD9604 was previously investigated as a potential obesity treatment, but the FDA has not approved it as a prescription medication (FDA PCAC briefing)